Featured essay
Lonza's five-site US buy from Merck KGaA won't close until mid-2027Lonza has agreed to take over the contract development and manufacturing business inside Merck KGaA's Life Science sector, covering five US facilities and about 1,100 employees, as PharmaSource's report on the five locations describes it. Closing is not expected until mid-2027,…
Read full essay